PHRAX | VRTPX | PHRAX / VRTPX | |
Total Expense Ratio | 1.24 | 0.08 | 1,550% |
Annual Report Gross Expense Ratio | 1.37 | 0.08 | 1,713% |
Fund Existence | 30 years | 8 years | - |
Gain YTD | 0.968 | 2.862 | 34% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 100000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 363M | 9.42B | 4% |
Annual Yield % from dividends | 1.86 | 3.97 | 47% |
Returns for 1 year | 7.26 | 12.93 | 56% |
Returns for 3 years | -4.83 | 16.16 | -30% |
Returns for 5 years | 8.21 | 35.61 | 23% |
Returns for 10 years | -42.02 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSOAX | 39.71 | 0.14 | +0.35% |
NYLI WMC Enduring Capital Class A | |||
GSMAX | 19.83 | N/A | N/A |
Goldman Sachs Small/Mid Cap Growth A | |||
ASEFX | 14.49 | N/A | N/A |
Nuveen Small Cap Select R6 | |||
PAHTX | 6.79 | N/A | N/A |
PGIM Jennison NextGeneration Glb Opps C | |||
TIDDX | 71.16 | N/A | N/A |
T. Rowe Price International Discovery I |